Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041664
Filing Date
2017-06-23
Accepted
2017-06-23 16:33:35
Documents
1
Period of Report
2017-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4226
  Complete submission text file 0001209191-17-041664.txt   5623
Mailing Address
Business Address
MANCHESTER KEITH S (Reporting) CIK: 0001244828 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 17927922

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations